Avadel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:AVDL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Dec 24	BuyUS$24,019	Thomas McHugh	Individual	2,300	US$10.44
11 Dec 24	BuyUS$52,433	Thomas McHugh	Individual	5,000	US$10.49
10 Dec 24	BuyUS$199,641	Geoffrey Glass	Individual	20,279	US$9.89
09 Dec 24	BuyUS$99,707	Gregory Divis	Individual	10,000	US$9.98
06 Dec 24	BuyUS$30,568	Linda Palczuk	Individual	3,000	US$10.19

Insider Trading Volume

Insider Buying: AVDL insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AVDL?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	939,654	0.975%
Hedge Funds	5,805,440	6.02%
General Public	7,072,117	7.34%
Institutions	82,544,317	85.7%

Dilution of Shares: AVDL only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 76.93% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
25.4%	Janus Henderson Group plc	24,452,217	US$257.0m	0.12%	0.11%
6.02%	Tontine Management, LLC	5,805,440	US$61.0m	1.14%	1.93%
5.46%	BlackRock, Inc.	5,257,004	US$55.3m	9.14%	no data
5.02%	Polar Capital Holdings Plc	4,834,028	US$50.8m	-26.3%	0.18%
4.01%	The Vanguard Group, Inc.	3,863,100	US$40.6m	4.65%	no data
3.52%	Braidwell LP	3,388,939	US$35.6m	16.9%	1.63%
2.79%	Vivo Capital, LLC	2,684,109	US$28.2m	-32.4%	2.39%
2.45%	Citadel Advisors LLC	2,358,546	US$24.8m	5.23%	0.03%
2.34%	Two Seas Capital LP	2,253,780	US$23.7m	6.55%	3.64%
2.32%	Wealth Effects LLC	2,233,771	US$23.5m	-1.5%	8.14%
1.88%	Goldman Sachs Group, Investment Banking and Securities Investments	1,810,512	US$19.0m	0%	0.01%
1.75%	Woodline Partners LP	1,687,313	US$17.7m	12.2%	0.16%
1.72%	Tri Locum Partners LP	1,660,955	US$17.5m	39.6%	4.06%
1.68%	State Street Global Advisors, Inc.	1,623,302	US$17.1m	42.5%	no data
1.43%	Brandes Investment Partners, LP	1,374,724	US$14.4m	-7.33%	0.1%
1.28%	Tang Capital Management, LLC	1,230,000	US$12.9m	0%	0.96%
1.2%	Geode Capital Management, LLC	1,154,365	US$12.1m	-0.56%	no data
1.14%	Checkpoint Capital, LLC, Asset Management Arm	1,100,000	US$11.6m	-3.35%	5.98%
1.01%	Millennium Management LLC	978,018	US$10.3m	7,010%	0.01%
1%	Samsara BioCapital LLC	967,527	US$10.2m	0%	1.37%
0.85%	SEB Investment Management AB	818,560	US$8.6m	24.3%	0.02%
0.73%	Medical Strategy GmbH, Asset Management Arm	703,144	US$7.4m	0%	0.45%
0.67%	UBS Asset Management AG	644,201	US$6.8m	175%	no data
0.67%	Morgan Stanley, Investment Banking and Brokerage Investments	641,547	US$6.7m	-10.2%	no data
0.63%	Altium Capital Management LP	610,000	US$6.4m	0%	2.05%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 03:16
End of Day Share Price	2025/01/02 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Avadel Pharmaceuticals plc is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Robin Garner Kalley	Craig-Hallum Capital Group LLC
Chase Knickerbocker	Craig-Hallum Capital Group LLC
Oren Livnat	H.C. Wainwright & Co.